Profound Medical (TSE:PRN) Trading Down 0.1% – Here’s What Happened

Profound Medical Corp. (TSE:PRN) fell 0.1% on Thursday . The company traded as low as C$8.53 and last traded at C$9.04. 24,735 shares changed hands during mid-day trading, an increase of 130% from the average session volume of 10,738 shares. The stock had previously closed at C$9.05.

Profound Medical Trading Down 0.1%

The company has a quick ratio of 14.98, a current ratio of 6.12 and a debt-to-equity ratio of 20.05. The firm has a market capitalization of C$271.68 million, a P/E ratio of -6.23 and a beta of -0.79. The firm has a 50 day moving average of C$7.47 and a 200-day moving average of C$7.46.

Profound Medical (TSE:PRN) last posted its quarterly earnings data on Thursday, November 13th. The company reported C$0.26 EPS for the quarter. The firm had revenue of C$7.36 million for the quarter. Profound Medical had a negative return on equity of 85.22% and a negative net margin of 349.41%. On average, equities research analysts predict that Profound Medical Corp. will post -1.9000001 earnings per share for the current fiscal year.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.